Search results

oh Facebook, so much more accurate. :rolleyes: your twitter link is the same false story. its a bond, not the company delisting.

the claimed reporting requirements will be financial reporting. a private (or worthless) pharma company would still have to report on their clinical trails, contrary to what this false info is trying to spin. the filing lists the class of security "0.250% Notes due 2022", that'll be some bond or...

what do you (or your video sources) think that shows? pages 30-39 are the Adverse Events of Special Interest list. thats a list of things that studies are looking out for and will report if seen. https://www.lawinsider.com/dictionary/adverse-event-of-special-interest-aesi